INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol CONNPLEX
MSEI Symbol NOTLISTED
ISIN INE0EAS01014
Name of Company CONNPLEX CINEMAS LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 10-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 04-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Half Yearly
Reporting Quarter Half yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment Entertainment Industry
Start date and time of board meeting 10-11-2025   15:00:00
End date and time of board meeting 10-11-2025   18:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 23-05-2025
Indicate Company website link for updated RPT policy of the Company https://theconnplex.com/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable


Financial Results — Other than Bank

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Revenue From Operations
Revenue from operations 6,405.99 6,405.99
Other income 50.58 50.58
Total Income 6,456.57 6,456.57
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 2,673.20 2,673.20
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (635.65) (635.65)
(d) Employee benefit expense 375.91 375.91
(e) Finance costs 7.44 7.44
(f) Depreciation and amortisation expense 95.31 95.31
(g) Other Expenses
1 Direct Expenses 1,429.81 1,429.81
2 Other Expenses 777.19 777.19
Total other expenses 2,207.00 2,207.00
Total expenses 4,723.21 4,723.21
3 Profit before exceptional and extraordinary items and tax 1,733.36 1,733.36
4 Exceptional items 0.00 0.00
5 Profit before extraordinary items and tax 1,733.36 1,733.36
6 Extraordinary items 0.00 0.00
7 Profit before tax 1,733.36 1,733.36
8 Tax Expense
Current tax 425.45 425.45
Deferred tax 2.53 2.53
Total tax expenses 427.98 427.98
9 Net Profit Loss for the period from continuing operations 1,305.38 1,305.38
10 Profit (loss) from discontinuing operations before tax 0.00 0.00
11 Tax expense of discontinuing operations 0.00 0.00
12 Net profit (loss) from discontinuing operation after tax 0.00 0.00
13 Profit (loss) for period before minority interest 1,305.38 1,305.38
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 1,305.38 1,305.38
17 Details of equity share capital
Paid-up equity share capital 1,910.00 1,910.00
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 8.51 8.51
Diluted earnings (loss) per share from continuing and discontinued operations 8.51 8.51
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio
23 Disclosure of notes on financial results Textual Information(1)


Text Block

Textual Information(1) Notes: 1. The standalone financial result for the half year ended September 30, 2025 have been prepared in accordance with the requirement of Accounting Standard (AS) prescribed under Section 133 of the Companies Act 2013 read with relevant rules thereunder and in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Company is exempted from the compulsory requirement of adoption of IND-AS. It has not adopted IND-AS for preparation of financial results. 2 The above Standalone unaudited financial result for the half year ended September 30, 2025 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on November 10, 2025 . 3. The comparative results and other information for the six months ended September 30, 2025 are not audited by the statutory auditors of the Company. The management has exercised necessary due diligence to ensure that the said comparative results provide a true and fair view of its affairs. 4. The Earning Per Share (EPS) have been computed in accordance with Accounting Standard on Earning Per Share (EPS) AS-20. The EPS for the Half year ended 30th september 2025 and 30th september2024 is not annualised. EPS for the respective periods have been calculated based on the weighted average number of shares outstanding as 30th September, 2025. 5. As Company's business activity falls within single primary business segment hence the disclosure requirement as per AS-17 Segment Reporting is not applicable. 6. The results for the half year ended September 30, 2025 will be available on the Stock Exchange website (www.nseindia.com) and on the Company's website(www.theconnplex.com). 7. There is no investor Complaints pending as on 30th september, 2025 8. In the current period, the Company has completed its initial public offer (IPO) of 51,00,000 Equity Shares of Rs. 10 each at an issue price of Rs. 177 per equity share (including security Premium Rs.167 per equity share). The issue was entirely fresh issue of Equity Shares for value aggregating to Rs.9,027.00 lakhs. Pursuant to IPO, the equity shares of the Company were listed on Emerge platform of National Stock Exchange of India Limited w.e.f. 14 August, 2025.


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect

Amount in (Lakhs)

A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 1,733.36
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 7.44
Adjustments for depreciation and amortisation expense 95.31
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for share-based payments 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (42.02)
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments to profit (loss) 60.73
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories (635.65)
Adjustments for decrease (increase) in trade receivables (941.68)
Adjustments for decrease (increase) in other current assets 261.68
Adjustments for increase (decrease) in trade payables 269.55
Adjustments for increase (decrease) in other current liabilities (411.86)
Adjustments for provisions 0.00
Total adjustments for working capital (1,457.96)
Total adjustments for reconcile profit (loss) (1,397.23)
Net cash flows from (used in) operations 336.13
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (425.45)
Net cash flows from (used in) operating activities before extraordinary items (89.32)
Proceeds from extraordinary items 0.00
Payment for extraordinary items 0.00
Net cash flows from (used in) operating activities (89.32)
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property plant and equipment (8.59)
Purchase of property plant and equipment 719.89
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 38.35
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (7,399.05)
Proceeds from government grants 0.00
Net cash flows from (used in) investing activities before extraordinary items (8,089.18)
Proceeds from extraordinary items 0.00
Payment for extraordinary items 0.00
Net cash flows from (used in) investing activities (8,089.18)
Cash flows from used in financing activities
Proceeds from issuing shares 8,357.08
Proceeds from issuing other equity instruments 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 119.70
Repayments of borrowings 0.00
Dividends paid 0.00
Interest paid 7.44
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (4.25)
Net cash flows from (used in) financing activities before extraordinary items 8,465.09
Proceeds from extraordinary items 0.00
Payment for extraordinary items 0.00
Net cash flows from (used in) financing activities 8,465.09
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 286.59
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 286.59
Cash and cash equivalents cash flow statement at beginning of period 190.69
Cash and cash equivalents cash flow statement at end of period 477.28


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 1,910.00
Reserves and surplus 10,217.33
Money received against share warrants 0.00
Total shareholders' funds 12,127.33
2 Share application money pending allotment 0.00
3 Deferred government grants 0.00
4 Minority interest
5 Non-current liabilities
Long-term borrowings 177.35
Deferred tax liabilities (net) 0.00
Foreign currency monetary item translation difference liability account 0.00
Other long-term liabilities 1,719.43
Long-term provisions 25.97
Total non-current liabilities 1,922.75
6 Current liabilities
Short-term borrowings 0.00
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 889.81
Total Trade payable 889.81
Other current liabilities 367.06
Short-term provisions 452.71
Total current liabilities 1,709.58
Total equity and liabilities 15,759.66
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 1,403.39
Producing properties 0.00
Intangible assets 0.07
Preproducing properties 0.00
Property, Plant and Equipment capital work-in-progress 486.49
Intangible assets under development or work-in-progress 0.00
Total Property, Plant and Equipment and Intangible assets 1,889.95
ii Non-current investments 7,603.45
v Deferred tax assets (net) 9.26
vi Foreign currency monetary item translation difference asset account 0.00
vii Long-term loans and advances 11.00
viii Other non-current assets 570.67
Total non-current assets 10,084.33
Current assets
Current investments 542.31
Inventories 1,373.32
Trade receivables 2,255.86
Cash and cash equivalents 477.32
Bank balance other than cash and cash equivalents 0.00
Short-term loans and advances 1.16
Other current assets 1,025.36
Total current assets 5,675.33
Total assets 15,759.66
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 12-08-2025
Amount Raised 9,027.00
Report filed for Quarter ended 30-09-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE Rating Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review The Audit Committee and the Board of Directors have reviewed the Monitoring Agency draft Report for the half year ended September 30, 2025. The Board noted that an amount of ₹0.62 crore was utilized from the General Corporate Purpose (GCP) portion towards tax payment (specifically, payment of TDS). The Board clarified that this payment represents a routine statutory obligation to the Government of India, as the Company regularly remits TDS every month in the normal course of its business operations. Accordingly, the said payment does not constitute an issue-related expense but forms part of the Company’s regular statutory compliances.
Comments of the auditors, if any No comment
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Funding Capital Expenditure requirement for purchase of Corporate Office Not Applicable 1,479.00 0.00 0.00 0.00
2 Funding Capital Expenditure requirement of purchase of LED Screens and Projectors Not Applicable 2,444.00 0.00 140.80 0.00
3 Funding Working Capital Requirement Not Applicable 3,763.00 0.00 89.79 0.00
4 Funding General Corporate Purpose Not Applicable 641.00 0.00 398.97 0.00
5 Public Issue related expenses Not Applicable 700.00 0.00 686.03 0.00


Signatory Details

Name of signatory Anish Tulshibhai Patel
Designation of person Managing Director
Place Ahmedabad
Date 12-11-2025


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 CONNPLEX CINEMAS LIMITED ANISH TULSHIBHAI PATEL Managing Director Remuneration NA 36.00 3.92 7.07
2 CONNPLEX CINEMAS LIMITED RAHUL KAMLESHBHAI DHYANI Joint Managing Director Remuneration NA 36.00 0.88 2.44
3 CONNPLEX CINEMAS LIMITED TULSHIBHAI KANJIBHAIPATEL Relative of Managing Director Remuneration NA 9.00 1.25 4.75
4 CONNPLEX CINEMAS LIMITED KAMLESHBHAI JAYANTILAL DHYANI Relative of Joint Managing Director Remuneration NA 4.50 9.70 14.20
5 CONNPLEX CINEMAS LIMITED POONAM ANISH PATEL Relative of Managing Director Remuneration NA 6.00 0.48 6.47
6 CONNPLEX CINEMAS LIMITED ARCHANA RAHUL DHYANI Relative of Joint Managing Director Remuneration NA 4.50 6.69 11.18
7 CONNPLEX CINEMAS LIMITED PUJAN ASHVINBHAI THAKKAR Chief Financial Officer Remuneration NA 5.94 0.66 1.03
8 CONNPLEX CINEMAS LIMITED RATIKA KHANDELWAL Company Secratery Remuneration NA 0.96 0.16 0.16
9 CONNPLEX CINEMAS LIMITED PARSHWA SHAH Independent Director Any other transaction Director Sitting Fees NA 0.70 0.00 0.32
10 CONNPLEX CINEMAS LIMITED RONAK ASHOKBHAI MEHTA Independent Director Any other transaction Director Sitting Fees NA 0.70 0.00 0.32
11 CONNPLEX CINEMAS LIMITED AMISHA FENIL SHAH Independent Director Any other transaction Director Sitting Fees NA 0.35 0.00 0.00
12 CONNPLEX CINEMAS LIMITED NILKANTH FILM FIESTA Entity in Which Director are Parttner Purchase of goods or services NA 39.35 2.48 4.21
13 CONNPLEX CINEMAS LIMITED NILKANTH FILM FIESTA Entity in Which Director are Parttner Sale of goods or services NA 35.65 12.48 11.90
14 CONNPLEX CINEMAS LIMITED CONNPLEX SKY THEATRE PRIVATE LIMITED Common Director Any other transaction Amount Receivable From NA 0.00 0.16 0.16
Total value of transaction during the reporting period 179.65